Literature DB >> 3434234

Blood-retinal barrier permeability versus diabetes duration and retinal morphology in insulin dependent diabetic patients.

B Krogsaa1, H Lund-Andersen, J Mehlsen, L Sestoft.   

Abstract

The blood-retinal barrier permeability to fluorescein was quantitated in 54 patients (22 females and 32 males) with insulin dependent diabetes mellitus (IDDM) of different duration. Correlation was demonstrated between permeability and diabetes duration. A normal permeability was measured in patients with up to ten years diabetes duration. A pathologically increased permeability was measured with ten to 15 years diabetes duration and during the next decade the permeability increased rapidly to 5-10 times the normal value. Onset of diabetes in the decade before and after puberty did not change the pattern. However, the pathologically increased permeability after ten years duration of the disease could not be demonstrated in diabetics with onset of the disease after the age of 30 years. The permeability of the blood-retinal barrier correlated well with changes in retinal morphology as seen by ophthalmoscopy and fluorescein angiography. However, there was an overlap in permeability between groups with different retinal appearance. A significant factor was the presence of macular edema, which also apparently indicated a preproliferative state.

Entities:  

Mesh:

Year:  1987        PMID: 3434234     DOI: 10.1111/j.1755-3768.1987.tb07064.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  11 in total

1.  Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy.

Authors:  M Larsen; E Hommel; H H Parving; H Lund-Andersen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

2.  Analysis of the blood-retinal barrier: its relation to clinical and metabolic factors and progression to retinopathy in juvenile diabetics. A 4-year follow-up study.

Authors:  A Castillo; J M Benitez del Castillo; D Diaz; O Sayagues; J L Ruibal; J Garcia-Sanchez
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-04       Impact factor: 3.117

Review 3.  Microvascular investigations in diabetes mellitus.

Authors:  S J Chittenden; S K Shami
Journal:  Postgrad Med J       Date:  1993-06       Impact factor: 2.401

4.  Diabetic macular oedema: a comparison of vitreous fluorometry, angiography, and retinopathy.

Authors:  B Sander; M Larsen; C Engler; C Strøm; B Moldow; N Larsen; H Lund-Andersen
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

5.  Clinical and metabolic factors associated with the blood retinal barrier permeability in insulin dependent diabetes mellitus without retinopathy.

Authors:  J M Benitez del Castillo; A Castillo; P C Fernandez; J Garcia Sanchez
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

6.  Blood-retina barrier permeability and its relation to the progression of diabetic retinopathy in type 1 diabetics. An 8-year follow-up study.

Authors:  C Engler; B Krogsaa; H Lund-Andersen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

7.  Effect of morphological abnormalities on blood retinal barrier permeability in diabetic retinopathy.

Authors:  J M van Gerven; J P Boot; H H Lemkes; J A van Best
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

Review 8.  Physiology of vitreous surgery.

Authors:  Einar Stefánsson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-26       Impact factor: 3.117

9.  Effect of bendazac lysine on lens and retina in diabetics.

Authors:  J M Benitez del Castillo; I Jimenez-Alfaro; P Ortega; A Castillo; D Diaz; N Toledano; J Garcia-Sanchez
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

10.  Blood retinal and blood aqueous barriers in diabetics by fluorophotometry.

Authors:  J P Boot; J M van Gerven; J A van Best; L Vrij; H H Lemkes; J A Oosterhuis
Journal:  Doc Ophthalmol       Date:  1989-01       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.